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Abstract
Background  and  objectives:  In  daily  clinical  practice,  pulmonary  complications  related  to  sur-
gical procedure  are  common,  increasing  the  morbidity  and  mortality  of  patients.  Assessment
of  the  risk  of  pulmonary  complications  is  an  important  step  in  the  preoperative  evaluation.
Thus,  we  review  the  most  relevant  aspects  of  preoperative  assessment  of  the  patient  with  lung
disease.
Content:  Pulmonary  risk  stratiﬁcation  depends  on  clinical  symptoms  and  patient’s  physical
status. Age,  preexisting  respiratory  diseases,  nutritional  status,  and  continued  medical  treat-
ment  are  usually  more  important  than  additional  tests.  Pulmonary  function  tests  are  of  great
relevance  when  high  abdominal  or  thoracic  procedures  are  scheduled,  particularly  when  lung
resection  are  considered.
Conclusion: Understanding  the  perioperative  evaluation  of  the  potential  risk  for  developing
pulmonary complication  allows  the  medical  team  to  choose  the  adequate  anesthetic  technique
and  surgical  and  clinical  care  required  by  each  patient,  thereby  reducing  adverse  respiratory
outcomes.
©  2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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ostoperative  complication  is  the  occurrence  of  an  unex-
ected change  that  affects  the  patient’s  welfare  or  deviates
rom the  expected  outcome  after  a  surgical  procedure.
ostoperative pulmonary  complications  (PPCs)  occur  within
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ttp://dx.doi.org/10.1016/j.bjane.2012.11.002hirty  days  after  the  surgical  procedure,  alter  the  clinical
icture of  the  patient,  and  may  require  drug  therapy  inter-
ention.
It is  known  that  most  surgical  procedures  is  related
o pulmonary  function  changes,1--3 usually  mild  or  moder-
te, but  occasionally  severe.4 Pulmonary  complications  are
mportant causes  of  perioperative  morbidity.5,6 It  has  been
eported in  1%--2%  of  all  patients  undergoing  minor  or  mid-
ize surgery  and  may  reach  10%--20%  in  those  undergoing
pper abdominal  or  thoracic  surgery.5,6 There  are  reports
hat acute  lung  injury  (ALI)  occurred  in  3%  of  patients  after
lective surgery,  a  major  cause  of  postoperative  respiratory
ailure.4
   lsevier  Editora  Ltda.  Este é um artigo Open Access sob a licença de CC BY-NC-ND
se  
r
p
d
t
p
w
p
r
c
h
l
p
A
G
f
f
o
e
o
n
i
g
i
i
t
a
a
s
b
r
t
w
i
e
w
v
p
d
r
o
r
t
s
b
a
d
c
t
e
pPreoperative  evaluation  of  the  patient  with  pulmonary  disea
Pulmonary  complications  may  be  classiﬁed  according  to
its potential  for  death  as  major  (respiratory  failure,  mechan-
ical ventilation  and/or  intubation  for  more  than  48  h,  and
pneumonia) or  minor  (purulent  tracheobronchitis,  atelecta-
sis with  clinical  and  bronchospasm).
The  achievement  of  adequate  preoperative  evaluation  of
pulmonary risk  allows  the  institution  of  measures  to  reduce
such complications  and  consequently  the  perioperative  mor-
bidity and  hospital  stay.  As  a  rule,  it  is  recommended  that
patients with  previous  respiratory  disease  are  evaluated  by
a pulmonologist.
Several predictors  were  identiﬁed  for  PPCs  and  are
related to  previous  clinical  conditions  and  characteristics
of the  anesthetic-surgical  procedure.  Age  over  60  years,
pre-existing lung  disease,  smoking,  and  previous  spiromet-
ric changes  (FEV1 <1  L)  are  associated  with  high  pulmonary
risk. Similarly,  duration  of  anesthesia  (>3  h),  head  and  neck
surgeries, chest  and  upper  abdomen  surgeries,  and  use  of
nasogastric tube  preoperatively  increase  the  incidence  of
respiratory events.
Because  pulmonary  complications  are  associated  with
worsening of  the  postoperative  outcome,7 in  this  article
we will  discuss  the  main  clinical  factors  and  strategies  in
order to  reduce  perioperative  pulmonary  complications  of
the surgical  patient.
Preoperative evaluation of the candidate for
general  surgical procedures
There  are  no  validated  models  of  pulmonary  risk  stratiﬁ-
cation. We  present  here  a  suggestion  for  initial  evaluation
based on  the  guidelines  of  the  American  College  of
Physicians8 and  on  the  outpatient  experience  of  preop-
erative evaluation  of  the  disciplines  of  Pneumology  and
Anesthesiology, Pain  and  Intensive  Care  Medicine  of  the
Escola Paulista  de  Medicina  (EPM-Unifesp).
All  assessment  depends  crucially  on  the  history  and
physical examination,  considering  the  additional  tests  ret-
rospectively,  which  will  be  requested  in  a  targeted  manner.
Risk factors  will  be  discussed  in  a  systematic  way  below.
Surgery-related  aspects
Usually,  in  surgical  procedures  with  no  cavity  opening  or
airway manipulation,  the  risk  for  PPCs  is  low.  Intra-cavity
procedures induce  major  changes  in  the  respiratory  system
compared to  peripheral  procedures.  Thoracic  and  abdomi-
nal surgeries  (especially  with  upper  abdomen  incisions)  are
the non-cardiac  procedures  with  a  higher  risk  of  pulmonary
complications.8--10 The  laparoscopic  approach  may  minimize
these changes,  but  it  does  not  eliminate  the  risk  of  PPCs.
Heart  surgery  has  a  peculiar  risk  for  PPCs.  In  myocardial
revascularization,  dissection  of  the  internal  thoracic  artery
may predispose  to  temporary  or  perennial  phrenic  nerve
injury. After  cardiopulmonary  bypass  (CPB),  pulmonary  dys-
function  is  well  described  but  poorly  understood.11 Although
the incidence  of  acute  respiratory  distress  syndrome  (ARDS)
after CPB  is  low  (<2%),  mortality  is  high  (>50%).12 During
CPB, both  lungs  are  kept  collapsed.  If  measures  are  not
taken immediately  after  the  end  of  CPB,  the  lungs  will
be slowly  recruited  and  more  than  half  of  the  lungs  can
a
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emain  atelectatic  one  to  two  days  after  surgery,  with  intra-
ulmonary shunt  around  20%--30%  of  cardiac  output.13 CPB
uration is  directly  related  to  the  incidence  of  postopera-
ive respiratory  complications,14 as  well  as  the  intensity  of
ulmonary interstitial  edema.15 Severe  pulmonary  changes
ith interstitial  and  alveolar  edema  may  occur  when  the
eriod of  CPB  exceed  150  min.14
A  surgical  time  greater  than  3  h  is  an  independent
isk factor  for  the  occurrence  of  postoperative  pulmonary
omplications. Emergency  surgeries  are  also  associated  with
igher incidence  of  PPCs,  as  there  is  no  time  to  stabi-
ize the  underlying  diseases  and  properly  prepare  for  the
rocedure.8
nesthesia-related  aspects
eneral  anesthesia  is  reported  in  several  studies  as  a  risk
actor for  PPCs.  The  use  of  neuromuscular  blocking  agents
or adequate  surgical  relaxation  may  be  an  important  cause
f respiratory  complications  and  development  of  postop-
rative hypoxemia.  This  is  primarily  due  to  the  presence
f residual  neuromuscular  block.16 The  use  of  long-term
euromuscular blocking  increases  this  effect  by  depress-
ng the  cough  reﬂex  and  allowing  the  microaspiration  of
astric contents.17 Prolonged  exposure  to  general  anesthet-
cs may  promote  changes  in  gas  exchange  and  temporary
mmunosuppression due  to  reduced  production  of  surfac-
ant, increased  alveolar--capillary  permeability,  impaired
lveolar macrophage  function,  and  slow  mucociliary  clear-
nce.
During general  anesthesia,  the  supine  position  and  inva-
ive ventilation  promote  changes  in  ventilatory  mechanics
ecause it  impairs  the  diaphragm  action,  resulting  in
educed volumes  and  lung  capacities.  As  a  result,  up
o 90%  of  anesthetized  patients  present  with  atelectasis,
hich promote  disturbances  in  ventilation-perfusion  (VA/Q),
mpair lung  compliance,  and  explain  the  onset  of  hypox-
mia. Persistent  atelectasis  postoperatively,  associated
ith transient  respiratory  muscle  dysfunction  and  eventual
entilation-dependent pain  after  thoracic  and/or  abdominal
rocedures result  in  increased  work  of  breathing11 (Table  1).
In  regional  anesthesia,  the  ventilatory  effects  will
epend on  the  type  and  extent  of  motor  blockade.  In  epidu-
al or  subarachnoid  extensive  anesthesia,  with  the  blockade
f basic  thoracic  segments,  there  is  a  reduction  in  inspi-
atory capacity  and  expiratory  reserve  volume  from  20%
o 0%.18 The  diaphragmatic  function,  however,  is  usually
pared, even  in  cases  of  inadvertent  extension  of  neuraxial
lock to  cervical  levels.19 Usually,  gas  exchange  is  minimally
ltered by  regional  anesthesia.
Thus,  blood  oxygenation  and  carbon  dioxide  elimination
uring epidural  and  spinal  anesthesia  are  preserved.  This
orroborates the  fact  that  there  is  a  reduction  in  func-
ional residual  capacity  and  change  in  the  ratio  VA/Q  during
pidural anesthesia.  Exception  occurs  with  morbidly  obese
atients in  which  blockade  of  the  abdominal  muscles  causes reduction  of  up  to  25%  in  forced  expiratory  volume  in  the
rst second  (FEV1)  and  forced  vital  capacity  (FVC),  in  addi-
ion to  interfering  with  the  ability  to  cough  and  eliminate
racheobronchial secretions.20 Epidural  anesthesia  has  the
24  
Table  1  Effects  of  anesthesia  on  respiratory  system.
1  Lung  parenchyma
Decreased  lung  volume  and  vital  capacity
Increased  closing  volume
Decreased lung  compliance
Increased ventilatory  work
2  Airways
Bronchodilation
(inhaled  anesthetics)
Bronchoconstriction
Decreased  mucociliary  clearance
3 Ventilatory  control
Reduced ventilatory  response  to  hypercapnia,
hypoxia,  and  acidosis
4  Pulmonary  circulation
Reduced reﬂex  vasoconstriction  to  hypoxia
(inhalation  anesthetics)
5  Gas  exchange
Increased  alveolar--arterial  O2 gradient  secondary  to
change in  VA/Q  ratio
6  Immune  function
Decreased  bactericidal  activity  of  alveolar  and
bronchial  macrophages
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Obstructive sleep  apnea  syndrome  (OSAS)  is  present  inIncreased release  of  proinﬂammatory  cytokines
dditional  advantages  of  reducing  the  need  for  opioids  and
ontributes to  adequate  postoperative  analgesia.
Interscalene  brachial  plexus  block  is  often  associated
ith ipsilateral  phrenic  nerve  block21,22 due  to  cephalad
pread of  anesthesia  and  the  nerve  bundle  proximity,  which
riginates in  the  cervical  roots  C3--C5.  After  interscalene
lock, the  incidence  of  hemidiaphragmatic  paralysis  reaches
00%.21,23--26 Thus,  changes  in  lung  mechanics  occur,  which
re potentially  harmful  to  patients  with  limited  respiratory
eserve. Reducing  the  volume  of  local  anesthetic  from  20
o 5  mL  through  brachial  plexus  block  guided  by  ultrasound
owered the  incidence  of  diaphragmatic  paralysis  from  100%
o 45%.27
In  healthy  patients,  diaphragmatic  paralysis  associated
ith brachial  plexus  block  usually  has  no  symptoms.  This
lock, however,  is  not  recommended  in  patients  with  severe
ulmonary disease.28 Urmey  and  McDonald23 contraindicate
nterscalene block  in  patients  who  cannot  tolerate  25%
eduction in  lung  function.
Altintas  et  al.29 reported  that  interscalene  block  with
upivacaine is  associated  with  a  greater  decrease  of  FVC,
EV1,  and  peak  expiratory  ﬂow  (PEF)  than  those  found  in
atients anesthetized  with  ropivacaine.  Regarding  analge-
ia, equipotent  doses  of  ropivacaine  produces  less  motor
lock and  greater  ability  to  blockade  the  A-delta  and  C  ﬁbers
han bupivacaine.30
atient-related  aspects
dvanced  age  is  associated  with  increased  risk  of  develop-
ng PPCs,  even  when  adjusted  for  comorbidities.  This  risk
ncreases signiﬁcantly  with  each  decade  of  life  after  60
ears.8 The  partial  or  total  dependence  to  perform  daily
u
m
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nd  instrumental  activities  is  also  associated  with  increased
isk of  PPCs.8
Cigarette  smoking  is  an  independent  risk  factor  for  the
ccurrence of  PPCs,  even  without  concomitant  chronic  lung
isease. The  impact  is  greater  in  patients  with  a  20  pack-
ear smoking  history  and  those  who  persisted  smoking  before
urgery.8,31
The  detrimental  effect  of  smoking  in  the  postoperative
eriod is  multifactorial  and  inﬂuenced  by  carbon  monoxide,
icotine, and  other  elements  capable  of  inducing  inﬂamma-
ion and  oxidative  stress.  The  proinﬂammatory  effects  of
igarette smoke  increases  the  incidence  of  cardiovascular
nd infectious  complications  and  hinders  the  surgical  wound
ealing, in  addition  to  being  associated  with  longer  hospital
nd intensive  care  unit  stays.32
Patients  with  BMI  ≥  40  kg  m−2 have  30%  chance  of
eveloping atelectasis  and/or  pneumonia  after  abdomi-
al surgery.  Additionally,  these  patients  have  an  increased
isk of  thromboembolism  and  wound  infection  compared
o normal  individuals.33 Similarly,  patients  who  evolve  with
cute weight  loss  and/or  malnutrition  with  hypoalbumine-
ia (serum  albumin  <3.5  g  L−1) also  have  a higher  incidence
f PPCs.8
Patients  with  preexisting  chronic  lung  disease,  such
s chronic  obstructive  pulmonary  disease  (COPD),  even
linically stable  and  with  controlled  disease,  have  substan-
ially increased  risk  of  PPCs.  Airway  management  in  these
atients may  lead  to  exacerbation  of  bronchial  inﬂamma-
ion with  worsening  of  hyperactivity  and  increased  risk
f bronchospasm.  Airway  chronic  bacterial  colonization
ssociated with  temporary  immunosuppression  induced  by
urgical procedure  and  increased  work  of  breathing  also  con-
ributes to  increase  complications.32 The  risk  and  severity
f postoperative  complications  are  generally  proportional
o the  degree  of  clinical  impairment  and  preoperative
pirometry (FEV1----moderate  if  between  50%  and  80%  and
evere if  <50%).  Prognosis  is  worse  in  patients  who  present
ith pulmonary  hypertension  and  need  for  home  oxygen
herapy.34,35
Although  restrictive  lung  diseases  appear  to  be  associated
ith adverse  respiratory  events,  the  literature  still  presents
ontroversial results.  General  anesthesia  and  mechani-
al ventilation  may  increase  the  risk  of  exacerbating  the
nﬂammatory process  of  parenchymal  ﬁbrotic  diseases  and
romote the  adult  respiratory  distress  syndrome.36
Similarly,  there  is  a  decrease  of  up  to  60%  of  spirometric
ariables in  scoliosis  correction  surgery,  and  many  of  these
atients already  have  severe  restrictive  lung  disease,  which
ontributes to  greater  delay  in  extubation.  The  peak  fall
n lung  volumes  occurs  on  the  third  day  after  surgery,  and
ecovery to  baseline  levels  may  take  up  to  two  months.37
Additionally  to  identifying  the  presence  of  chronic  lung
iseases, it  is  also  necessary  to  assess  the  degree  of  symp-
om control  with  the  speciﬁc  treatment  used  at  that  time.
atients often  tend  to  overestimate  their  lung  condition,
o it  is  recommended  that  the  physician  actively  ask  about
espiratory symptoms,  preferably  with  the  use  of  standard-
zed questionnaires.p to  22%  of  the  adult  population  undergoing  surgical  treat-
ent, but  almost  70%  of  them  have  no  diagnosis  prior  to
reoperative assessment.38 Thus,  the  active  investigation
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Directed history and physical examination
Preoperative screening for OSAS
(STOPBang, Berlin or ASA)
+
Low risk OSAS High risk OSAS Patient diagnosed with OSAS
Proceed to surgery with the usual
perioperative care Identify the patient with wristband
Intraoperative management
• Consider regional anesthesia with minimal sedation. 
•  Prepare for difficult airway. Consider CPAP and raise headboard to 25° to increase FRC; use of drugs
with short duration of action.
• Consider invasive monitoring for respiratory and hemodynamic management.
•  Extubation with the patient fully awake and after neuromuscular blockade reversal.
Anesthesia recovery management
• Careful observation of oxygen saturation and hemodynamic monitoring.
• Observe headboard elevation to 30° and/or lateral position for at least two hours in most patients.
• Consider non-opioid analgesics and regional anesthesia. Use of opioid with discretion. 
• Early use of CPAP in case of desaturation.
In-hospital management
• Monitor the patient at the appropriate hospital site that can provide continuous oxygen monitoring. 
•  Use of CPAP if previously diagnosed with OSAS or on CPAP therapy preoperatively.
Management for hospital discharge
• Follow-up with sleep expert for polysomnography, diagnostic, and treatment. 
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of  symptoms,  such  as  snoring,  episodes  of  apnea  observed
by the  caregiver,  and  non-restorative  sleep  with  exces-
sive daytime  sleepiness  should  be  routinely  included  in  the
preoperative medical  history.  The  observed  characteristics
predisposing to  the  existence  of  OSAS  include  male  gen-
der, age  over  50  years,  BMI  >30  kg  m−2,  neck  circumference
>40 cm,  deviated  septum,  tonsillar  hypertrophy,  laryngo-
malacia, tracheomalacia,  Down  syndrome,  micrognathia,
achondroplasia, acromegaly,  and  macroglossia.  There  are
validated questionnaires  to  screen  for  OSAS  in  the  periop-
erative period,  such  as  the  Berlin  questionnaire,39 ASA  OSA
scoring checklist,40 and  STOP-Bang41 (Table  2).  Fig.  1  shows
the steps  suggested  for  managing  patients  with  OSAS  under-
going elective  surgery.42
On  the  ﬁrst  postoperative  day,  there  is  fragmentation
and decreased  total  sleep  time,  with  suppressed  REM  sleep.
(
s
a
e OSA  patients  undergoing  elective  surgery.
n  subsequent  days,  REM  sleep  rebound  and  the  conse-
uent worsening  of  sleep  apnea  have  been  associated  with
he occurrence  of  PPCs  and  cardiovascular  complications.
he use  of  sedatives  and  analgesics  (especially  opioids  and
enzodiazepines) also  contributes  by  decreasing  pharyn-
eal tone.  The  presence  of  OSAS  increases  the  length  of
tay and  the  chances  of  hypoxemia  and  reintubation  in  the
ostoperative period,  besides  being  associated  with  greater
ncidence of  arrhythmias,  acute  coronary  syndrome,  and
udden death.42
Patients  with  clinically  controlled  diseases  (physical  sta-
us P  II)  are  known  to  have  lower  perioperative  mortality
0.2%).8 Thus,  patients  with  inadequate  clinical  control  of
ymptoms (P  III  and  IV)  must  ﬁrst  receive  maximized  ther-
py before  undergoing  anesthesia  and  surgical  procedures,
xcept in  emergency  surgery.
26  
Table  2  STOP-Bang  score  used  as  OSAS  screening  in  preop-
erative evaluation.
Analyzed  variable  Question  to  be  asked/examination
ﬁndings
S  Snoring  Do  you  Snore  Loudly?  Louder  than
talking  or  loud  enough  to  be  heard
through  a  closed  door?
T Tiredness  Do  you  often  feel  Tired?  Do  you
sleep  during  the  daytime?
O Observed  apnea  Has  anyone  observed  you  stop
breathing  during  sleep?
P Pressure Do  you  have  high  blood  pressure?
B BMI  BMI  >  35  kg  m−2
A  Age  Over  50  years
N Neck  Circumference  >40  cm
G Gender  Male
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eHigh risk for OSAS: ≥3 positive responses.
Low risk for OSAS: <3 positive responses.
Chronic  alcoholism  with  more  than  60  g  dia−1 ethanol  con-
umption increases  up  to  twice  the  risk  of  perioperative
cute lung  injury  in  candidates  for  lung  resection  surgery,43
n  addition  to  predisposing  to  infections  and  bleeding.  Acute
ensory changes,  delirium,  previous  stroke,  and  chronic  use
f  corticosteroids  are  also  independent  risk  factors  for  PPCs.
ole  of  additional  medical  tests  in  pulmonary  risk
valuation
edical  history  and  physical  examination  are  in  most  cases
ufﬁcient to  determine  the  pulmonary  risk  involved  in  gen-
ral surgery.  Blood  tests,  chest  X-ray  and  pulmonary  function
est should  only  be  ordered  when  the  results  actually  involve
hanging the  strategy  planned  for  the  initial  evaluation.
reoperative arterial  blood  gases  should  not  be  required
outinely, except  in  patients  with  chronic  lung  disease  and
oderate to  severe  airway  obstruction  on  spirometry.
Multicenter  prospective  studies  showed  that  urea  dosage
bove 21  mg  dL−1 and  serum  albumin  below  3.5  g  dL−1
ere  predictors  of  PPCs,  particularly  pneumonia  and  acute
espiratory failure  in  postoperative  noncardiac  surgery.8
erioperative  mortality  was  also  higher  in  patients  with
erum creatinine  greater  than  1.5  g  dL−1,  due  to  both  pul-
onary and  infectious  and  cardiovascular  and  hemorrhagic
dverse events.44
Although  chest  X-ray  is  frequently  ordered  in  the  preop-
rative evaluation,  its  importance  is  questioned.  In  up  to
3% of  these  tests,  an  abnormal  ﬁnding  is  seen,  but  in  only
.1%--3% of  cases,  the  pre-established  medical  approach  is
hanged.45 Chest  X-ray  is  more  important  in  patients  with
rior cardiopulmonary  disease,  those  older  than  40  years
r who  will  undergo  medium  and  major  surgeries,  particu-
arly thoracic  and  abdominal  or  surgical  correction  of  aortic
neurysm.46
Among  the  recognized  tests  to  assess  lung  function,
pirometry is  universally  known  and  most  requested  during
reoperative evaluation.  However,  as  a  predictor  of  pul-
onary adverse  events  in  the  postoperative  period,  it  is  not
s  good  as  the  clinical  evaluation.  Its  use  in  intra-abdominal
t
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p
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nd  thoracic  procedures  without  pulmonary  resection  has
een  considered  in  the  following  situations:  patients  with
nown chronic  lung  disease,  smokers  or  exposed  to  inhalants
ong enough  to  cause  structural  lung  injury,  and  those  with
hronic respiratory  symptoms  or  ﬁndings  on  physical  or
adiological examination  suggestive  of  chronic  pulmonary
isease.47
Other  situations  in  which  spirometry  is  considered  are:
andidates for  bariatric  surgery,  patients  with  kyphoscoliosis
ndergoing general  anesthesia,  chronic  lung  disease  under-
oing neurosurgery,  and  neuromuscular  patients  undergoing
eneral anesthesia.  In  patients  with  neuromuscular  disease
r kyphoscoliosis,  measurements  of  maximal  inspiratory  and
xpiratory pressures  should  also  be  ordered.  FVC  below  40%
f the  predicted  value  and/or  maximum  pressures  below
0 cm  H2O  signiﬁcantly  increases  the  risk  of  extubation  fail-
re in  postoperative  period.45,47 Contrary  to  what  occurs  in
ung resection  surgery,  there  are  no  FEV1 prohibitive  limits
or performing  general  surgeries.
In  patients  with  pulmonary  arterial  hypertension  (PAH),
reoperative evaluation  should  include  electrocardiogram
t rest  and  echocardiography,  in  addition  to  6-min  walk  test
6MWT). The  presence  of  right  atrial  pressure  >77  mm  Hg
t the  last  hemodynamic  assessment  before  surgery,  6MWT
istance walked  <399  m,  greater  clinical  severity,  and
mergency surgery  are  indicative  of  greater  postoperative
orbidity and  mortality.48 Cardiopulmonary  exercise  testing
s routinely  used  in  the  clinical  evaluation  of  patients  with
AH to  establish  prognosis  and  assess  therapeutic  response.
owever, although  it  may  help  to  stratify  the  severity  of  dis-
ase, its  role  in  predicting  the  surgical  risk  for  these  patients
s still  limited.
isk stratiﬁcation of postoperative pulmonary
omplications
urrently,  there  are  no  validated  stratiﬁcation  models  of
ulmonary risk  in  general  surgery.  However,  the  American
ollege of  Physicians  adopted  some  scales  for  assessing  the
isk of  speciﬁc  respiratory  complications,9,10 such  as  acute
espiratory failure  (Table  3)  and  pneumonia  (Table  4).  The
merican Society  of  Anesthesiologists  has  developed  a  risk
core for  prediction  of  respiratory  complications  in  patients
ith OSAS40 (Table  5).
articularities of the preoperative evaluation
or  lung resection surgery
here  is  a  clear  association  between  the  extent  of  pulmonary
esection and  perioperative  morbidity  and  mortality.  Mortal-
ty rate  after  pneumonectomy  is  up  to  two-fold  higher  than
hat of  lobectomy.  Similarly,  the  mortality  rates  of  segmen-
ectomy and  lumpectomy  are  inferior  to  that  of  lobectomy,
specially if  performed  by  thoracoscopy.49
Unlike  general  surgery,  preoperative  evaluation  of
atients scheduled  for  pulmonary  resection  requires  spirom-
try testing  and,  if  necessary,  cardiopulmonary  exercise
esting (CPET).  For  a  complete  assessment,  it  is  necessary  to
ombine functional  imaging  data  from  computed  tomogra-
hy, pulmonary  perfusion  scintigraphy,  and  bronchoscopy.
hese tests  aim  to  assess  whether  the  area  to  be  resected
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Table  3  Risk  factors  for  acute  respiratory  failure  in  post-
operative period  of  general  non-cardiac  surgery.
Risk  factor  Score
Abdominal  aortic  aneurysm  repair  27
Thoracic 14
Upper abdominal,  peripheral  or  vascular
neurosurgery
21
Neck  11
Emergency surgery  11
Albumin <3.0  mg  dL−1 9
Plasma urea  >30  mg  dL−1 8
Totally or  partly  dependent  functional  status 7
COPD  6
Age ≥70  years  6
Age 60--69  years  4
Class Score  %Risk
1  ≤10  0.5
2 11--19  1.8
3 20--27  4.2
4 28--40  10.1
5  ≥40  26.6
Table  4  Risk  factors  for  postoperative  pneumonia  in  gen-
eral non-cardiac  surgery.
Risk  factor  Score
Type  of  surgery
Abdominal  aortic  aneurysm  repair  15
High thoracic  14
High abdominal  10
Neck or  neurosurgery  08
Vascular 03
Age (years)
≥80  17
70--79 13
60--69 09
50--59 04
Functional status
Totally dependent  10
Partially dependent  6
Weight loss  over  10%  in  the  last  6  months 7
COPD 5
General anestesia 4
Altered sensorium 4
Prior stroke 4
Urea (mg  dL−1)
<8 4
22--30 2
≥30 3
Blood transfusion  greater  than  4  units  3
Emergency surgery  3
Chronic use  of  corticosteroids  3
Smoking in  the  last  year  3
Alcohol intake  >2  doses  in  the  previous  2  weeks  2
Class Score  %Risk
1  0--15  0.24
2 16--25  1.2
3 26--40  4.0
4 41--55  9.4
5 >55  15.8
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still  participates  in  pulmonary  gas  exchange,  and  the  ﬁnal
calculation should  be  done  to  estimate  the  residual  values
of pulmonary  function  after  the  scheduled  resection.  FEV1 is
the spirometric  parameter  used  most  often  for  this  purpose,
followed by  carbon  monoxide  diffusion  (DLCO)  or  maximal
oxygen uptake  (VO2max)  obtained  in  CPET.  The  ppo  desig-
nation is  added  to  indicate  that  the  estimated  parameter
refers to  the  late  postoperative  period;  i.e.,  three  to  six
months after  the  surgical  procedure  (FEV1-ppo,  DLCO-ppo,
and VO2max-ppo).
The simplest  calculation  uses  the  number  of  functioning
lung segments  (right  upper  lobe  =  3,  middle  lobe  =  2,  right
lower lobe  =  5,  left  upper  lobe  =  3  of  the  upper  division  +2
of the  lingula  and  left  lower  lobe  =  4)  and  assumes  that  all
segments contribute  equally  to  gas  exchange,  which  is  rarely
true in  unhealthy  lungs.50 This  method  is  used  to  estimate
the function  after  lobectomy  and  the  following  formulas  may
be  applied:
Mode  1  :  ppo  value  =
(
preoperative  value
T
)
×  R
T  =  19  −  number  of  obstructed  segments;  R  =  T  −  number  of
functioning segments  to  be  resected.
Mode  2  :  ppo  value  =  preoperative  value  ×
(
1  − a
b
)
a  =  number  of  non-obstructed  segments  to  be  resected;
b =  total  number  of  non-obstructed  segments.For pneumonectomy,  the  calculation  should  be  made
using the  results  of  perfusion  scintigraphy  or  pulmonary
ventilation. Perfusion  examination  is  the  most  commonly
used method  for  this  purpose.  In  this  case,  the  formula
t
i
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rRisk assessment for postoperative pneumonia in general non-
cardiac  surgery.
sed  for  the  calculation  is:  ppo  value  =  preoperative
alue ×  (1  −  perfusion  fraction  of  the  lung  to  be  resected).
Traditionally,  the  estimated  postoperative  values  of  FEV1
nd/or  DLCO  less  than  30%  were  considered  absolute  con-
raindications for  lung  resection  due  to  the  high  incidence
f cardiorespiratory  complications  and  death  in  the  post-
perative period.  Likewise,  values  between  30%  and  40%
requently imposed  more  risks  than  the  anticipated  bene-
ts of  surgery;  therefore,  cardiopulmonary  exercise  testing
CPET) is  mandatory  in  this  group  of  patients.51
However,  the  advent  of  minimally  invasive  surgical  tech-
iques, such  as  video-assisted  thoracic  surgery  (VATS),  and
he possibility  of  performing  viable  lung  parenchyma  spar-
ng resections  have  allowed  patients  with  ppo  FEV1 and/or
LCO <  40%  to  undergo  these  procedures  with  morbidity
ates relatively  low  (15--25%)  and  postoperative  mortality
28  
Table  5  The  American  Society  of  Anesthesiologists  score
for postoperative  complication  assessment  in  patients  with
OSAS.
A:  Severity  of  sleep  apnea  based  on  sleep  study  (or  clinical
indicators  if  sleep  study  not  available)
None  =  0,  mild  =  1,  moderate  =  2,  severe  =  3
Subtract  1  point  in  patients  using  CPAP  or  BiPAP
Add  1  point  for  patients  with  PaCO2 >50  mm  Hg
B:  Surgery  and  anesthesia
Superﬁcial surgery  under  local  anesthesia  or  peripheral
nerve  block  =  0
Superﬁcial  surgery  with  moderate  sedation  or  general
anesthesia  or  peripheral  surgery  with  epidural  anesthesia
(up  to  moderate  sedation)  =  1
Peripheral  surgery  with  general  anesthesia  or  airway
surgery  with  moderate  sedation  =  2
Major  surgery  or  airway  surgery  with  general
anesthesia  =  3
C:  Requirement  for  postoperative  opioids
None  =  0,  low  oral  dose  =  1,  high  oral  dose  or  parenteral
or neuroaxial  =  3
D:  Estimation  of  perioperative  risk
Global  risk  =  A  score  +  greater  score  for  B  or  C
Patients with  global  risk  ≥4  may  be  at  increased
perioperative  risk  for  OSAS
Patients with  global  risk  ≥5  may  be  at  signiﬁcantly
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anging  from  1%  to  15%,  reported  in  the  literature.52--54
n  these  patients,  surgery  to  treat  lung  cancer  in  stage  I,
ven with  minor  resections  (sublobar  resections)  result  in
ncreased survival  compared  to  patients  who  did  not  undergo
he procedure.55 Moreover,  tumor  resection  in  patients  with
evere COPD  may  have  a  reduced  functional  impact  in  two
ituations: (1)  tumor  is  located  in  the  upper  lobe,  which  is
lso the  site  of  major  involvement  of  centrilobular  emphy-
ema and,  therefore,  with  less  functional  loss;  (2)  if  there  is
he possibility  of  combining  tumor  resection  with  lung  vol-
me reduction  surgery,  if  the  patient  is  a  candidate  for  this
rocedure.56--60
Accordingly,  it  became  necessary  to  develop  a  broader
ethod of  preoperative  evaluation  for  lung  resection
urgery, allowing  risk  stratiﬁcation  less  focused  on  simple
ung function  parameters  and  more  related  to  the  individ-
al’s ability  to  perform  his  daily  activities.  The  ﬂowchart
ecently developed  and  published  on  the  guidelines  for
ung cancer  from  the  American  College  of  Chest  Physicians
Fig. 2)  is  based  on  this  concept.61 Under  the  new  guidelines,
atients with  ppo  FEV1 and/or  DLCO  >60%  are  considered
t low  risk  for  surgery,  with  an  estimated  mortality  rate
1%, and  do  not  require  additional  pulmonary  evaluation.
atients with  ppo  FEV1 and/or  DLCO  between  30%  and  60%
hould undergo  simple  exercise  tolerance  test  as  a  screening
ethod. Those  who  reach  a  walk  distance  >400  m  on  the
huttle walk  test  or  are  able  to  climb  >22  m  on  the  stair
limbing test  are  also  considered  at  low  risk  and  do  not
equire additional  pulmonary  evaluation.  On  the  other  hand,
f these  cut-off  values  are  not  achieved,  CPET  should  be
c
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ompulsorily  performed  for  surgical  risk  stratiﬁcation.  Like-
ise, patients  with  ppo  VEF1 and/or  DLCO  <30%  also  have
bsolute indication  to  perform  the  CPET.
Portable  spirometry  has  very  limited  availability  in
linical practice,  but  it  is  an  important  tool  for  preopera-
ive evaluation  of  individuals  scheduled  for  lung  resection
urgery. VO2max  values  (oxygen  uptake  at  peak  exercise)
bove 20  mL  kg−1 min−1 or  75%  higher  than  expected  ensure  a
afe surgical  approach  (low  risk).62 This  value  indicates  that
he patient’s  functional  reserve  is  sufﬁcient  to  withstand
he stress  of  surgery  and  perform  daily  activities  in  the  late
ostoperative period.  Patients  with  VO2max  between  10  and
0 mL  kg−1 min−1 or  between  35%  and  75%  of  the  expected
alue are  at  moderate  risk  for  perioperative  complications,
ut these  values  are  not  prohibitive,  provided  that  the  ben-
ﬁt of  surgery  is  considered  to  outweigh  the  risks.63 Values
elow mL  kg−1 min−1 or  <35%  of  the  expected  mean  high  risk
nd are  generally  considered  a  contraindication  to  surgery
ue to  the  high  mortality  rate  (>10%).64
CPET  provides  data  on  cardiovascular  performance  dur-
ng exercise,  which  have  prognostic  importance  and  may
irectly or  indirectly  inﬂuence  risk  stratiﬁcation.  For  exam-
le, this  is  the  case  of  parameters  such  as  aerobic  efﬁciency
VO2/W),  oxygen  pulse  (VO2/HR),  and  the  ratio  minute-
olume/CO2 production  (VE/VCO2).  Based  on  the  foregoing,
he adoption  of  cardiac  risk  as  an  indication  for  perform-
ng CPET  was  included  in  the  new  protocol  for  functional
ssessment of  lung  resection  surgery.  Patients  with  Tho-
acic Revised  Cardiac  Risk  Index  (ThRCRI)65,66 ≥2,  who  are
nable to  climb  two  ﬂights  of  stairs  or  have  heart  disease
equiring medication  or  newly  diagnosed,  should  be  initially
valuated by  a  cardiologist  and  undergo  diagnostic  tests  and
reatments according  to  protocols  for  perioperative  evalu-
tion of  the  cardiology  societies.  After  this  initial  step,  all
atients considered  at  high  cardiac  risk  should  undergo  a
PET (Fig.  2).
erioperative strategies to reduce the risk of
ostoperative  pulmonary complications
he  ultimate  goal  of  preoperative  evaluation  and  risk  assess-
ent for  PPCs  lies  in  the  individualization  of  perioperative
trategies able  to  reduce  the  calculated  risk.  In  some  high-
isk situations  without  strategies  to  decrease  it,  special
ttention should  be  paid  to  early  diagnosis  of  PPCs,  and
ggressive treatment  should  be  done  to  reduce  mortality.
idactically, we  tried  to  group  strategies  into  preoperative,
ntraoperative, and  postoperative.
reoperative  strategies
peciﬁc  therapy  should  be  optimized  to  ensure  that  the
atient achieves  the  best  possible  clinical  and  functional
ondition. If  there  is  evidence  of  exacerbations,  the  use
f corticosteroids  alone  or  combined  with  antibiotics  may
e necessary  and,  in  such  cases,  it  is  recommended  that
urgery be  postponed  for  at  least  30  days  after  the  processIn stable  patients,  the  recommendation  is  that  the  medi-
ation should  not  be  discontinued  even  on  the  day  of  surgery.
n symptomatic  patients,  even  with  optimal  medication
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Spirometry
Cardiac risk
Low or
moderate
High*
ppo FEV1 and
DLCO <60% Low risk
p2po
FEV1 and DLCO
between 30-60%
Stair-climbing test or
shuttle walk test
>22 m or >400 m
<22 m or <400 m
ppo FEV1 and
DLCO <30%
Cardiopulmonary
exercise testing
VO2max <10
ml/kg/min or
<35%
VO2max between
10-20 ml/kg/min or
35-75%
VO2max >20
ml/kg/min or
>75%
Moderate
risk
High
risk
*High cardiac risk :
New heart disease
Heart disease requiring medication
ThRCI (Thoracic revised Cardiac Risk Index) ≥2, where:
- pneumonectomy: 1.5 points
- DAC: 1.5 tos pon
- previous stroke or TIA: 1.5 points
- creatinina sé rica  > 2mg/dl: 1 ponto
serum creatinine> 2mg/dl: 1 point
Other factors such as comorbidities, age, surgical approach
(thoracotomy vs minimally invasive) and center experience
ent  u
h
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d
•
•
•
dFigure  2  Evaluation  of  the  pati
and  undergoing  major  or  midsize  elective  surgery,  the
hospitalization three  to  ﬁve  days  before  the  procedure
may be  beneﬁcial  because  it  allows  the  administration  of
intravenous corticosteroids  and  fast  action  inhaled  bron-
chodilators on  a  ﬁxed  schedule,  in  addition  to  respiratory
therapy. In  patients  with  uncontrolled  persistent  cough
receiving corticosteroids  and  bronchodilators,  the  use  of
cough suppressants  may  be  useful.
In  the  patient  with  bronchial  hyperreactivity  undergoing
general anesthesia  with  endotracheal  intubation,  starting
with systemic  steroids  orally  ﬁve  days  before  the  procedure
is recommended.  Moreover,  immediately  before  surgery,  the
patient should  receive  short  duration  inhaled  beta-2  and
full doses  of  anticholinergics  associated  with  intravenous
corticosteroids.67--69
Patients  with  lung  disease  are  often  chronic  users  of  cor-
ticosteroids, either  as  maintenance  or  prescribed  treatment
at exacerbation  times.  Thus,  those  using  doses  of  pred-
nisone >7.5  mg  or  equivalent  for  more  than  30  days  or  >20  mg
for more  than  two  weeks  in  the  past  year  are  considered
at risk  for  developing  postoperative  adrenal  insufﬁciency.46Patients  treated  with  radiotherapy  to  the  pituitary  region,
with autoimmune  diseases  or  a  clinical  diagnosis  suggestive
of adrenal  insufﬁciency,  are  also  considered  at  risk.  Ideally,
they should  undergo  diagnostic  evaluation  prior  to  surgery;
r
o
n
bndergoing  pulmonary  resection.
owever,  if  there  is  not  enough  time  for  the  investigation,
mpirical corticosteroid  supplementation  is  recommended,
epending on  the  size  of  surgery:46
 Mild  surgical  stress:  double  or  triple  the  daily  dose  of  cor-
ticosteroids  used  for  patients  with  a  previous  diagnosis  of
adrenal  insufﬁciency  or  chronic  corticosteroid  users.  In
case  of  fasting,  prescribe  hydrocortisone  (50  mg)  immedi-
ately  before  surgery  with  25  mg  maintenance  every  12  h
for  up  to  24  h  after  the  procedure.
 Moderate  surgical  stress:  parenteral  hydrocortisone
(25 mg  every  8  h),  beginning  on  the  morning  of  surgery
and with  dose  reduction  of  50%/day  postoperatively  up  to
suspension  or  achieving  the  regular  dose.
 High  surgical  stress:  parenteral  hydrocortisone  (50  mg
every  6  h),  beginning  on  the  morning  of  surgery  and  with
dose  reduction  of  50%/day  postoperatively  up  to  suspen-
sion  or  achieving  the  regular  dose.
Cigarette  smoking  increases  the  risk  of  perioperative  car-
iac and  pulmonary  complications.  Smoking  abstinence  can
educe  the  rate  of  such  complications.70 However,  the  pre-
perative period  of  abstinence  required  for  this  beneﬁt  is
ot established.  Some  experts  suggest  that  abstinence  for  a
rief period  before  surgery  (often  deﬁned  as  less  than  eight
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eeks)  may  have  an  increased  risk  of  PPCs.  The  supposed
echanism for  this  increased  risk  is  a  transient  increase
n cough  and  mucous  production  after  abstinence.  How-
ver, there  are  several  studies  that  found  no  relationship
etween increased  risk  and  a  short  period  of  abstinence.71
ecent  meta-analysis  concluded  that  the  available  evidence
oes not  support  the  association  between  short  period  of
bstinence and  increased  postoperative  risk.72 In  outpa-
ients, smoking  cessation  is  not  associated  with  increased
ough or  sputum  production,73 and  sputum  production  dur-
ng surgery  is  not  increased  in  recent  ex-smokers  (abstinence
ight weeks  before  surgery)  compared  to  those  who  contin-
ed smoking.74 Thereby:  (1)  there  is  no  study  reporting  that
bstinence from  smoking  in  a  short  interval  preoperatively
igniﬁcantly increases  pulmonary  risk;  (2)  meta-analysis  of
vailable studies  showed  no  signiﬁcant  increased  risk;  (3)
here  is  no  support  for  the  supposed  underlying  mechanism
hat contributes  to  the  risk;  (4)  there  is  no  evidence  of
educed PPCs  in  subjects  undergoing  surgery  after  a  period
f four  weeks  abstinence.75 Thus,  preoperative  evaluation
hould be  considered  an  important  measure  to  encourage
moking cessation,  regardless  of  the  period  in  which  it  has
een made.
Cognitive-behavioral strategies,  associated  with  spe-
iﬁc drugs  or  not  so  (nicotine  replacement  therapy,76
upropion,76 varenicline77),  are  effective  in  smoking  cessa-
ion and  may  be  used  both  pre-  and  postoperatively.  The
hoice of  drug  treatment  should  take  into  account  individ-
al patient  contraindications  and  not  be  changed  by  the
ype of  surgery.  Nicotine  patches  may  be  used  even  in  the
mmediate postoperative  period.46
Respiratory  physiotherapy  is  crucial  for  reducing  the  risk
f perioperative  pulmonary  complications.  It  can  be  started
efore surgery  and  maintained  throughout  hospitalization
n order  to  maximize  lung  function  and  minimize  respi-
atory symptoms.  Preoperative  respiratory  muscle  training
an reduce  the  incidence  of  atelectasis  and  increase  by
0% the  mean  value  of  postoperative  maximum  inspiratory
ressure.78
The  strategies  that  can  be  applied  by  physiotherapists
re varied  and  include:  incentive  spirometer,  sustained  deep
reathing exercises,  assisted  coughing,  postural  drainage,
ercussion and  vibration,  and  use  of  intermittent  noninva-
ive ventilation  (CPAP  or  BiPAP).  Meta-analysis  showed  a  50%
eduction of  perioperative  complications  with  the  use  of
ncentive spirometer  and  deep  breathing  exercises,  but  so
ar, there  is  no  evidence  of  superiority  of  one  strategy  over
he other.
ntraoperative  strategies
nesthesia  causes  respiratory  impairment,  whether  the
atient is  maintained  on  spontaneous  or  mechanical  ven-
ilation. This  impairment  prevents  the  adequacy  of  alveolar
entilation and  perfusion  and,  consequently,  blood  oxygen-
tion. An  important  factor  for  respiratory  impairment  during
eneral anesthesia  with  the  patient  in  spontaneous  ventila-
ion is  the  reduction  of  CO2 sensitivity  caused  by  inhalational
nesthetics,79 barbiturates,80 and  opioids.81 The  response  is
ose dependent  and  there  is  a  direct  relationship  between
entilation reduction  and  anesthetic  depth.  This  does  not
o
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reclude  the  use  of  spontaneous  ventilation  during  inhala-
ional anesthesia  in  children82 and  adults,83 performed  under
onitoring and  appropriate  adjustment.
The  use  of  neuromuscular  blockers  for  adequate  surgical
elaxation intraoperatively  may  be  an  important  cause  of
espiratory complications  and  onset  of  postoperative  hypox-
mia. This  is  primarily  because  of  the  presence  of  residual
euromuscular block.16 Thus,  the  evaluation  of  patients  with
he use  of  quantitative  neuromuscular  blockade  monitors
hould be  considered 17,84--88,  particularly  when  long-acting
lockers such  as  pancuronium  are  used.
There  is  evidence  that  inhaled  anesthetics,  such  as
soﬂurane89 and  sevoﬂurane,90 may  reduce  the  ventilation-
nduced lung  injury  (VILI).  Preconditioning  with  isoﬂurane
n the  lungs  and  other  organs  mimics  the  cardiopro-
ective effect  of  ischemic  preconditioning91 through  the
ctivation of  adenosine  receptors92 and  ATP-sensitive  potas-
ium channels.93 Isoﬂurane  induces  protective  effects
uring ischemia--reperfusion94 and  lung  injury  induced  by
ndotoxin95 or  zymosan.96 There  are  also  beneﬁts  in  reduc-
ng cytokine  release  caused  by  mechanical  ventilation,97 in
ddition to  a  protective  effect  against  lung  injury  by  avoid-
ng pro-inﬂammatory  responses.89
Balanced  anesthesia  should  be  used  in  patients  with
bstructive lung  diseases  due  to  the  action  of  inhaled
ronchodilator. Desﬂurane  should  be  used  sparingly  due  to
he effect  of  coughing,  laryngospasm,  bronchospasm,  and
ronchial hypersecretion.98.99
In  regional  anesthesia  for  upper  limb  surgery,  inter-
calene brachial  plexus  block  with  large  volume  of  local
nesthetic should  be  avoided  in  severe  chronic  lung  disease
atients, as  there  is  a  risk  of  ipsilateral  diaphragmatic  paral-
sis. Preferably,  plexus  block  should  be  performed  under
irect visualization  with  ultrasound  and  minimum  local  anes-
hetic volumes.100
In  the  intra-and  postoperative  periods,  ﬂuid  replacement
hould be  made  with  caution  and  excessive  administration
f ﬂuids  and  positive  ﬂuid  balance  avoided.  The  excessive
ntravascular volume  leads  to  extravasation  of  ﬂuid  into  the
nterstitium and  predisposes  to  acute  lung  injury  and  respi-
atory failure,101 wound  infection,  anastomotic  dehiscence,
nd postoperative  ileus.  Moreover,  positive  balance  often
enerates extubation  difﬁculties,  resulting  in  longer  intu-
ation time  and  ICU  stay.  Thus,  ﬂuid  replacement  should
referably be  based  on  macro  and  micro-hemodynamic
arameters.102
The  use  of  a  nasogastric  tube  (NGT)  increases  the  risk
f microaspirations  and,  consequently,  pulmonary  infections
n the  postoperative  period.  Thus,  its  routine  use  should  be
bandoned and  the  passage  of  NGT  restricted  to  patients
ith a  clear  indication.103
ostoperative  strategies
he  decision  to  request  that  the  ﬁrst  post-operative  care  of
 patient  be  made  in  the  ICU  depends  on  the  size  of  the
urgery, severity  of  the  patient’s  condition,  and  risk  of  peri-
perative complications.  Thus,  the  recommendation  should
e  made  judiciously  from  careful  preoperative  evaluation.
Analgesics  that  depress  the  respiratory  system  should
e avoided  whenever  possible.  In  OSA  patients,  the  use  of
se  Preoperative  evaluation  of  the  patient  with  pulmonary  disea
systemic  opioids  is  known  to  worsen  the  airway  obstruction
and increase  the  incidence  of  postoperative  complications.
Therefore, the  use  of  simple  analgesics  (dipyrone,  para-
cetamol) and  hormonal  or  non-hormonal  anti-inﬂammatory
drugs is  recommended  for  cases  of  mild  pain.  For  mod-
erate to  severe  pain,  ketamine  or  dexmedetomidine  can
reduce opioid  requirements.104 In  cases  of  regional  anesthe-
sia, maintaining  catheters  for  postoperative  local  analgesia
is recommended.
Postoperatively, patients  with  spontaneous  breathing
should be  evaluated  regarding  the  need  for  supplemental
oxygen by  facemask  or  catheter  through  blood  gas  analy-
sis and  pulse  oximetry.  Especially  in  patients  with  COPD,
OSAS and/or  heart  failure,  the  use  of  noninvasive  ventila-
tion if  respiratory  distress  occurs  may  avoid  reintubation.
OSA patients  have  higher  risk  of  developing  hypoxemia  and
hypercapnia postoperatively  and  should  be  handled  with
CPAP routinely  as  soon  as  they  are  admitted  to  the  ICU  or
ward.
Patients on  invasive  mechanical  ventilation  should  be
immediately included  in  weaning  protocols  and,  whenever
possible, ventilated  in  pressure  support  mode.  Deep  seda-
tion and  analgesia  should  be  avoided,  aiming  at  scores  of  2
or 3  on  the  Ramsay  scale,  and  respecting  the  sedation  proto-
col of  daily  interruption.  Respiratory  therapy  and  endurance
workouts also  help  to  reduce  the  time  of  intubation.
Except  in  cases  of  contraindication  due  to  the  surgical
procedure nature,  the  head  should  be  kept  at  30◦ inclina-
tion. This  measure  not  only  helps  prevent  airway  obstruction
in patients  with  spontaneous  ventilation,  but  has  also  proven
to reduce  the  incidence  of  ventilator-associated  pneumonia.
Conclusions
Preoperative  evaluation  of  patients  with  respiratory  diseases
should be  made  in  candidates  to  elective  or  emergency
surgery, as  there  is  the  possibility  of  establishing  measures
that reduce  the  risk  of  complications  during  intra-  and
postoperative periods.  In  any  of  these  situations,  the  ini-
tial assessment  is  clinical,  and  complementary  examinations
should be  requested  based  on  this  assessment.  In  elective
procedure, the  goals  of  preoperative  assessment  can  be
more widely  attained;  namely,  clinical  stabilization  of  lung
disease, maximizing  lung  function,  smoking  cessation,  and
early institution  of  preoperative  respiratory  therapy.
Finally,  lung  disease  patients  often  present  with  other
comorbidities and  should  be  globally  assessed  for  cardio-
vascular, metabolic,  renal,  and  venous  thromboembolism
risks involved  in  the  anesthetic-surgical  procedure  to  be
performed.
Conﬂicts of interest
The  authors  declare  no  conﬂicts  of  interest.
References1. Hedenstierna G, Edmark L. Mechanisms of atelectasis in
the perioperative period. Best Pract Res Clin Anaesthesiol.
2010;24:157--69.31
2. Valenza F, Chevallard G, Fossali T, Salice V, Pizzocri M,
Gattinoni L. Management of mechanical ventilation dur-
ing laparoscopic surgery. Best Pract Res Clin Anaesthesiol.
2010;24:227--41.
3.  Duggan M, Kavanagh BP. Perioperative modiﬁcations of
respiratory function. Best Pract Res Clin Anaesthesiol.
2010;24:145--55.
4.  Fernandez-Perez ER, Sprung J, Afessa B, et al. Intraoperative
ventilator settings and acute lung injury after elective surgery:
a  nested case control study. Thorax. 2009;64:121--7.
5.  Kroenke K, Lawrence VA, Theroux JF, Tuley MR, Hilsenbeck S.
Postoperative complications after thoracic and major abdom-
inal surgery in patients with and without obstructive lung
disease. Chest. 1993;104:1445--51.
6. Licker M, Diaper J, Villiger Y, et al. Impact of intraoperative
lung-protective interventions in patients undergoing lung can-
cer  surgery. Crit Care. 2009;13:R41.
7. Lawrence VA, Hilsenbeck SG, Mulrow CD, Dhanda R, Sapp
J, Page CP. Incidence and hospital stay for cardiac and pul-
monary complications after abdominal surgery. J Gen Intern
Med. 1995;10:671--8.
8. Smetana GW, Lawrence VA, Cornell JE. Preoperative pul-
monary risk stratiﬁcation for noncardiothoracic surgery:
systematic review for the American College of Physicians. Ann
Intern Med. 2006;144:581--95.
9. Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifacto-
rial risk index for predicting postoperative respiratory failure
in  men after major noncardiac surgery. The National Veter-
ans Administration Surgical Quality Improvement Program. Ann
Surg.  2000;232:242--53.
10. Arozullah AM, Khuri SF, Henderson WG, Daley J. Development
and validation of a multifactorial risk index for predicting
postoperative pneumonia after major noncardiac surgery. Ann
Intern  Med. 2001;135:847--57.
11. Apostolakis EE, Koletsis EN, Baikoussis NG, Siminelakis SN,
Papadopoulos GS. Strategies to prevent intraoperative lung
injury during cardiopulmonary bypass. J Cardiothorac Surg.
2010;5:1.
12.  Ng CS, Wan S, Yim AP, Ariﬁ AA. Pulmonary dysfunction after
cardiac surgery. Chest. 2002;121:1269--77.
13. Tenling A, Hachenberg T, Tyden H, Wegenius G, Hedenstierna
G. Atelectasis and gas exchange after cardiac surgery. Anes-
thesiology. 1998;89:371--8.
14. Hachenberg T, Tenling A, Hansson HE, Tyden H, Hedenstierna
G. The ventilation--perfusion relation and gas exchange in
mitral valve disease and coronary artery disease. Implica-
tions for anesthesia, extracorporeal circulation, and cardiac
surgery. Anesthesiology. 1997;86:809--17.
15.  Ratliff NB, Young Jr WG, Hackel DB, Mikat E, Wilson
JW. Pulmonary injury secondary to extracorporeal circula-
tion. An ultrastructural study. J Thorac Cardiovasc Surg.
1973;65:425--32.
16.  Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T.
The  inﬂuence of residual neuromuscular block on the incidence
of critical respiratory events. A randomised, prospec-
tive, placebo-controlled trial. Eur J Anaesthesiol. 2011;28:
842--8.
17.  Berg H, Roed J, Viby-Mogensen J, et al. Residual neuro-
muscular block is a risk factor for postoperative pulmonary
complications. A prospective, randomised, and blinded study
of  postoperative pulmonary complications after atracurium,
vecuronium and pancuronium. Acta Anaesthesiol Scand.
1997;41:1095--103.
18.  Yamakage M, Namiki A, Tsuchida H, Iwasaki H. Changes in ven-
tilatory pattern and arterial oxygen saturation during spinal
anaesthesia in man. Acta Anaesthesiol Scand. 1992;36:569--71.
19.  Warner DO, Warner MA, Ritman EL. Human chest wall function
during epidural anesthesia. Anesthesiology. 1996;85:761--73.
3patients after lobar pulmonary resection. Eur J Cardiothorac2  
20. Regli A, von Ungern-Sternberg BS, Reber A, Schneider MC.
Impact of spinal anaesthesia on peri-operative lung volumes
in obese and morbidly obese female patients. Anaesthesia.
2006;61:215--21.
21.  Urmey WF, Talts KH, Sharrock NE. One hundred percent
incidence of hemidiaphragmatic paresis associated with
interscalene brachial plexus anesthesia as diagnosed by ultra-
sonography. Anesth Analg. 1991;72:498--503.
22.  Casati A, Fanelli G, Cedrati V, Berti M, Aldegheri G, Torri
G. Pulmonary function changes after interscalene brachial
plexus anesthesia with 0.5% and 0.75% ropivacaine: a double-
blinded comparison with 2% mepivacaine. Anesth Analg.
1999;88:587--92.
23.  Urmey WF, McDonald M. Hemidiaphragmatic paresis during
interscalene brachial plexus block: effects on pulmonary
function and chest wall mechanics. Anesth Analg. 1992;74:
352--7.
24.  Al-Kaisy A, McGuire G, Chan VW, et al. Analgesic effect
of interscalene block using low-dose bupivacaine for outpa-
tient arthroscopic shoulder surgery. Reg Anesth Pain Med.
1998;23:469--73.
25.  Singelyn FJ, Seguy S, Gouverneur JM. Interscalene brachial
plexus analgesia after open shoulder surgery: contin-
uous versus patient-controlled infusion. Anesth Analg.
1999;89:1216--20.
26.  Urmey WF, Gloeggler PJ. Pulmonary function changes dur-
ing interscalene brachial plexus block: effects of decreasing
local anesthetic injection volume. Reg Anesth. 1993;18:
244--9.
27.  Riazi S, Carmichael N, Awad I, Holtby RM, McCartney CJ. Effect
of  local anaesthetic volume (20 vs 5 ml) on the efﬁcacy and
respiratory consequences of ultrasound-guided interscalene
brachial plexus block. Br J Anaesth. 2008;101:549--56.
28.  Gottardis M, Luger T, Florl C, et al. Spirometry, blood gas
analysis and ultrasonography of the diaphragm after Win-
nie’s interscalene brachial plexus block. Eur J Anaesthesiol.
1993;10:367--9.
29.  Altintas F, Gumus F, Kaya G, et al. Interscalene brachial
plexus block with bupivacaine and ropivacaine in patients with
chronic renal failure: diaphragmatic excursion and pulmonary
function changes. Anesth Analg. 2005;100:1166--71.
30.  Heavner JE. Cardiac toxicity of local anesthetics in the
intact isolated heart model: a review. Reg Anesth Pain Med.
2002;27:545--55.
31.  Warner MA, Divertie MB, Tinker JH. Preoperative cessation
of smoking and pulmonary complications in coronary artery
bypass patients. Anesthesiology. 1984;60:380--3.
32.  Licker M, Schweizer A, Ellenberger C, Tschopp JM, Diaper J,
Clergue F. Perioperative medical management of patients with
COPD.  Int J Chron Obstruct Pulmon Dis. 2007;2:493--515.
33.  Von Ungern-Sternberg BS, Regli A, Schneider MC, Kunz F, Reber
A.  Effect of obesity and site of surgery on perioperative lung
volumes. Br J Anaesth. 2004;92:202--7.
34. Jaber S, Delay JM, Chanques G, et al. Outcomes of
patients with acute respiratory failure after abdominal surgery
treated with noninvasive positive pressure ventilation. Chest.
2005;128:2688--95.
35. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon
MD. Impact of pulmonary hypertension on the outcomes of
noncardiac surgery: predictors of perioperative morbidity and
mortality. J Am Coll Cardiol. 2005;45:1691--9.
36.  Honma K, Tango Y, Isomoto H. Perioperative management of
severe interstitial pneumonia for rectal surgery: a case report.
Kurume Med J. 2007;54:85--8.
37. Yuan N, Fraire JA, Margetis MM, Skaggs DL, Tolo VT, Keens
TG. The effect of scoliosis surgery on lung function in
the immediate postoperative period. Spine (Phila Pa 1976).
2005;30:2182--5.L.H.  Degani-Costa  et  al.
38. Finkel KJ, Searleman AC, Tymkew H, et al. Prevalence of
undiagnosed obstructive sleep apnea among adult surgical
patients in an academic medical center. Sleep Med. 2009;10:
753--8.
39. Chung F, Ward B, Ho J, Yuan H, Kayumov L, Shapiro C.
Preoperative identiﬁcation of sleep apnea risk in elective sur-
gical  patients, using the Berlin questionnaire. J Clin Anesth.
2007;19:130--4.
40. Gross JB, Bachenberg KL, Benumof JL, et al. Practice guide-
lines for the perioperative management of patients with
obstructive sleep apnea: a report by the American Society
of Anesthesiologists Task Force on Perioperative Management
of patients with obstructive sleep apnea. Anesthesiology.
2006;104:10817--1093, quiz 117--118.
41.  Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a
tool  to screen patients for obstructive sleep apnea. Anesthe-
siology. 2008;108:812--21.
42. Adesanya AO, Lee W, Greilich NB, Joshi GP. Periop-
erative management of obstructive sleep apnea. Chest.
2010;138:1489--98.
43.  Licker M, de Perrot M, Spiliopoulos A, et al. Risk factors for
acute lung injury after thoracic surgery for lung cancer. Anesth
Analg. 2003;97:1558--65.
44. O’Brien MM, Gonzales R, Shroyer AL, et al. Modest serum creat-
inine elevation affects adverse outcome after general surgery.
Kidney Int. 2002;62:585--92.
45. Archer C, Levy AR, McGregor M. Value of routine preoperative
chest x-rays: a meta-analysis. Can J Anaesth. 1993;40:1022--7.
46.  Gualandro DM, Yu PC, Calderaro D, et al. II Guidelines for peri-
operative evaluation of the Brazilian Society of Cardiology. Arq
Bras  Cardiol. 2011;96:1--68.
47. Zibrak JD, O’Donnell CR, Marton K. Indications for pulmonary
function testing. Ann Intern Med. 1990;112:763--71.
48.  Meyer S, McLaughlin VV, Seyfarth HJ, et al. Out-
come of non-cardiac, non-obstetric surgery in patients
with pulmonary arterial hypertension: results from an
international prospective survey. Eur Respir J. 2012,
http://dx.doi.org/10.1183/09031936.00089212.
49.  Damhuis RA, Schutte PR. Resection rates and postoperative
mortality in 7,899 patients with lung cancer. Eur Respir J.
1996;9:7--10.
50.  Wyser C, Stulz P, Soler M, et al. Prospective evaluation of an
algorithm for the functional assessment of lung resection can-
didates. Am J Respir Crit Care Med. 1999;159:1450--6.
51.  Beckles MA, Spiro SG, Colice GL, Rudd RM. The physiologic
evaluation of patients with lung cancer being considered for
resectional surgery. Chest. 2003;123:105S--14S.
52.  Lau KK, Martin-Ucar AE, Nakas A, Waller DA. Lung cancer
surgery in the breathless patient -- the beneﬁts of avoiding
the gold standard. Eur J Cardiothorac Surg. 2010;38:6--13.
53.  Linden PA, Bueno R, Colson YL, et al. Lung resection in
patients with preoperative FEV1 <35% predicted. Chest.
2005;127:1984--90.
54.  Martin-Ucar AE, Fareed KR, Nakas A, Vaughan P, Edwards JG,
Waller DA. Is the initial feasibility of lobectomy for stage I non-
small  cell lung cancer in severe heterogeneous emphysema
justiﬁed by long-term survival? Thorax. 2007;62:577--80.
55.  Donington J, Ferguson M, Mazzone P, et al. American Col-
lege of Chest Physicians and Society of Thoracic Surgeons
consensus statement for evaluation and management for high-
risk  patients with stage I non-small cell lung cancer. Chest.
2012;142:1620--35.
56. Bobbio A, Chetta A, Carbognani P, et al. Changes in pulmonary
function test and cardio-pulmonary exercise capacity in COPDSurg. 2005;28:754--8.
57. Brunelli A, Xiume F, Refai M, et al. Evaluation of expiratory
volume, diffusion capacity, and exercise tolerance following
se  Preoperative  evaluation  of  the  patient  with  pulmonary  disea
major lung resection: a prospective follow-up analysis. Chest.
2007;131:141--7.
58.  Kushibe K, Takahama M, Tojo T, Kawaguchi T, Kimura M,
Taniguchi S. Assessment of pulmonary function after lobec-
tomy for lung cancer -- upper lobectomy might have the same
effect as lung volume reduction surgery. Eur J Cardiothorac
Surg. 2006;29:886--90.
59. Luzzi L, Tenconi S, Voltolini L, et al. Long-term respiratory
functional results after pneumonectomy. Eur J Cardiothorac
Surg. 2008;34:64--8.
60. Varela G, Brunelli A, Rocco G, Jimenez MF, Salati M, Gatani T.
Evidence of lower alteration of expiratory volume in patients
with airﬂow limitation in the immediate period after lobec-
tomy. Ann Thorac Surg. 2007;84:417--22.
61. Brunelli A, Kim AW,  Berger KI, Addrizzo-Harris DJ. Physiologic
evaluation of the patient with lung cancer being consid-
ered for resectional surgery: diagnosis and management of
lung cancer, 3rd ed: American College of Chest Physicians
evidence-based clinical practice guidelines. Chest. 2013;143:
e166S--90S.
62.  Brunelli A, Belardinelli R, Refai M, et al. Peak oxygen con-
sumption during cardiopulmonary exercise test improves risk
stratiﬁcation in candidates to major lung resection. Chest.
2009;135:1260--7.
63. Win T, Jackson A, Sharples L, et al. Cardiopulmonary
exercise tests and lung cancer surgical outcome. Chest.
2005;127:1159--65.
64.  Holden DA, Rice TW, Stelmach K, Meeker DP. Exercise testing,
6-min walk, and stair climb in the evaluation of patients at
high risk for pulmonary resection. Chest. 1992;102:1774--9.
65.  Brunelli A, Varela G, Salati M, et al. Recalibration of the revised
cardiac risk index in lung resection candidates. Ann Thorac
Surg. 2010;90:199--203.
66. Ferguson MK, Celauro AD, Vigneswaran WT. Validation of
a  modiﬁed scoring system for cardiovascular risk associ-
ated with major lung resection. Eur J Cardiothorac Surg.
2012;41:598--602.
67.  Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci.
1993;52:521--7.
68. Groeben H, Silvanus MT, Beste M, Peters J. Combined
lidocaine and salbutamol inhalation for airway anesthesia
markedly protects against reﬂex bronchoconstriction. Chest.
2000;118:509--15.
69.  Groeben H, Schlicht M, Stieglitz S, Pavlakovic G, Peters
J. Both local anesthetics and salbutamol pretreatment
affect reﬂex bronchoconstriction in volunteers with asthma
undergoing awake ﬁberoptic intubation. Anesthesiology.
2002;97:1445--50.
70.  Warner DO. Perioperative abstinence from cigarettes:
physiologic and clinical consequences. Anesthesiology.
2006;104:356--67.
71.  Theadom A, Cropley M. Effects of preoperative smoking
cessation on the incidence and risk of intraoperative and post-
operative complications in adult smokers: a systematic review.
Tob Control. 2006;15:352--8.
72. Myers K, Hajek P, Hinds C, McRobbie H. Stopping smok-
ing shortly before surgery and postoperative complications:
a systematic review and meta-analysis. Arch Intern Med.
2011;171:983--9.
73. Warner DO, Colligan RC, Hurt RD, Croghan IT, Schroeder DR.
Cough following initiation of smoking abstinence. Nicotine Tob
Res.  2007;9:1207--12.
74. Yamashita S, Yamaguchi H, Sakaguchi M, et al. Effect of
smoking on intraoperative sputum and postoperative pul-
monary complication in minor surgical patients. Respir Med.
2004;98:760--6.
75.  Nakagawa M, Tanaka H, Tsukuma H, Kishi Y. Relationship
between the duration of the preoperative smoke-free period33
and  the incidence of postoperative pulmonary complications
after pulmonary surgery. Chest. 2001;120:705--10.
76.  Billert H, Gaca M, Adamski D. Smoking cessation as regards
anesthesia and surgery. Przegl Lek. 2008;65:687--91.
77.  Wong J, Abrishami A, Yang Y, et al. A perioperative
smoking cessation intervention with varenicline: a double-
blind, randomized placebo-controlled trial. Anesthesiology.
2012;117(4):755--64.
78.  Dronkers J, Veldman A, Hoberg E, van der Waal C, van
Meeteren N. Prevention of pulmonary complications after
upper abdominal surgery by preoperative intensive inspira-
tory muscle training: a randomized controlled pilot study. Clin
Rehabil. 2008;22:134--42.
79. Sakai EM, Connolly LA, Klauck JA. Inhalation anesthesiology
and volatile liquid anesthetics: focus on isoﬂurane, desﬂurane,
and sevoﬂurane. Pharmacotherapy. 2005;25:1773--88.
80.  von Ungern-Sternberg BS, Frei FJ, Hammer J, Schibler A,
Doerig R, Erb TO. Impact of depth of propofol anaesthesia
on functional residual capacity and ventilation distribution in
healthy preschool children. Br J Anaesth. 2007;98:503--8.
81.  Pattinson KT. Opioids and the control of respiration. Br J
Anaesth. 2008;100:747--58.
82. Ansermino JM, Magruder W,  Dosani M. Spontaneous respiration
during intravenous anesthesia in children. Curr Opin Anaesthe-
siol. 2009;22:383--7.
83. Luginbuhl M, Vuilleumier P, Schumacher P, Stuber F. Anesthe-
sia or sedation for gastroenterologic endoscopies. Curr Opin
Anaesthesiol. 2009;22:524--31.
84. Herbstreit F, Peters J, Eikermann M. Impaired upper airway
integrity by residual neuromuscular blockade: increased air-
way  collapsibility and blunted genioglossus muscle activity
in response to negative pharyngeal pressure. Anesthesiology.
2009;110:1253--60.
85.  Murphy GS, Szokol JW, Marymont JH, et al. Intraoperative
acceleromyographic monitoring reduces the risk of resid-
ual neuromuscular blockade and adverse respiratory events
in the postanesthesia care unit. Anesthesiology. 2008;109:
389--98.
86.  Berg H. Is residual neuromuscular block following pancuronium
a risk factor for postoperative pulmonary complications? Acta
Anaesthesiol Scand Suppl. 1997;110:156--8.
87.  Bissinger U, Schimek F, Lenz G. Postoperative residual paralysis
and respiratory status: a comparative study of pancuronium
and vecuronium. Physiol Res. 2000;49:455--62.
88.  Murphy GS, Szokol JW, Franklin M, Marymont JH, Avram
MJ, Vender JS. Postanesthesia care unit recovery times and
neuromuscular blocking drugs: a prospective study of ortho-
pedic surgical patients randomized to receive pancuronium
or rocuronium. Anesth Analg. 2004;98:193--200 [table of con-
tents].
89. Faller S, Strosing KM, Ryter SW, et al. The volatile anes-
thetic isoﬂurane prevents ventilator-induced lung injury via
phosphoinositide 3-kinase/Akt signaling in mice. Anesth Analg.
2012;114:747--56.
90.  Schlapfer M, Leutert AC, Voigtsberger S, Lachmann RA, Booy C,
Beck-Schimmer B. Sevoﬂurane reduces severity of acute lung
injury possibly by impairing formation of alveolar oedema. Clin
Exp  Immunol. 2012;168:125--34.
91. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze
M, Menasche P. Evidence for preconditioning by isoﬂu-
rane in coronary artery bypass graft surgery. Circulation.
1999;100:II340--4.
92.  Roscoe AK, Christensen JD, Lynch 3rd C. Isoﬂurane, but
not halothane, induces protection of human myocardium via
adenosine A1 receptors and adenosine triphosphate-sensitive
potassium channels. Anesthesiology. 2000;92:1692--701.
93.  Jiang MT, Nakae Y, Ljubkovic M, Kwok WM, Stowe DF, Bosn-
jak ZJ. Isoﬂurane activates human cardiac mitochondrial
31
1
1
14  
adenosine triphosphate-sensitive K+ channels reconstituted
in lipid bilayers. Anesth Analg. 2007;105:926--32 [table of
contents].
94.  Fujinaga T, Nakamura T, Fukuse T, et al. Isoﬂurane inhalation
after circulatory arrest protects against warm ischemia reper-
fusion injury of the lungs. Transplantation. 2006;82:1168--74.
95.  Li QF, Zhu YS, Jiang H, Xu H, Sun Y. Isoﬂurane preconditioning
ameliorates endotoxin-induced acute lung injury and mortality
in  rats. Anesth Analg. 2009;109:1591--7.
96. Mu J, Xie K, Hou L, et al. Subanesthetic dose of isoﬂurane
protects against zymosan-induced generalized inﬂammation
and its associated acute lung injury in mice. Shock. 2010;34:
183--9.
97.  Vaneker M, Santosa JP, Heunks LM, et al. Isoﬂurane attenu-
ates pulmonary interleukin-1beta and systemic tumor necrosis
factor-alpha following mechanical ventilation in healthy mice.
Acta  Anaesthesiol Scand. 2009;53:742--8.
98. Dikmen Y, Eminoglu E, Salihoglu Z, Demiroluk S. Pulmonary
mechanics during isoﬂurane, sevoﬂurane and desﬂurane
anaesthesia. Anaesthesia. 2003;58:745--8.
1L.H.  Degani-Costa  et  al.
99.  Volta CA, Alvisi V, Petrini S, et al. The effect of volatile
anesthetics on respiratory system resistance in patients
with chronic obstructive pulmonary disease. Anesth Analg.
2005;100:348--53.
00.  Falcão LF, Perez MV, de Castro I, et al. Minimum effective
volume of 0.5% bupivacaine with epinephrine in ultrasound-
guided interscalene brachial plexus block. Br J Anaesth.
2013;110:450--5.
01.  Holte K, Jensen P, Kehlet H. Physiologic effects of intra-
venous ﬂuid administration in healthy volunteers. Anesth
Analg. 2003;96:1504--9 [table of contents].
02.  Grocott MP, Mythen MG, Gan TJ. Perioperative ﬂuid man-
agement and clinical outcomes in adults. Anesth Analg.
2005;100:1093--106.
03.  Nelson R, Edwards S, Tse B. Prophylactic nasogastric decom-
pression after abdominal surgery. Cochrane Database Syst Rev.
2005;25(1):CD004929.
04.  Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine:
a review of clinical applications. Curr Opin Anaesthesiol.
2008;21:457--61.
